Skip to content
Esta página está disponible en españolCambiar →

H World Group (HTHT): which funds own it

Consumer Discretionary →Data as of Jun 30, 2026 (Q2 2026) · updated on Nov 5, 2026

A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.

Sections with a free account

10 concentrated managers hold it (+1 vs last quarter) with a median weight of 0.5%.

Who owns H World Group?

H World Group trades in the U.S. through ADRs, certificates that represent shares of a non-U.S. company. Form 13F counts ADRs while the company reports ordinary shares, so we do not compute percentages. Holders reporting more than 5% of the ordinary shares to the SEC (Schedules 13D/13G): Qi Ji, 23.3% (13D/A filed Oct 20, 2025), Tong Tong Zhao, 8.5% (13D/A filed Oct 20, 2025) and JPMorgan Chase, 5.0% (13G filed Oct 13, 2026). As of Jun 30, 2026, the largest ADR holders reported on Form 13F were Schroder Investment Management Group (14.9 million ADRs), Capital International Investors (12.5 million ADRs) and JPMorgan Chase (12.2 million ADRs).

Which institutions hold the most H World Group shares?

Per Form 13F filings as of Jun 30, 2026, in ADRs:

  1. 1. Schroder Investment Management Group: 14.9 million ADRs
  2. 2. Capital International Investors: 12.5 million ADRs
  3. 3. JPMorgan Chase: 12.2 million ADRs
  4. 4. Invesco: 10.2 million ADRs
  5. 5. Mitsubishi UFJ Trust & Banking: 9.1 million ADRs
  6. 6. BlackRock: 8.9 million ADRs
  7. 7. M&g: 6.1 million ADRs
  8. 8. FMR: 4.5 million ADRs
  9. 9. Perseverance Asset Management International: 4.0 million ADRs
  10. 10. Kontiki Capital Management (HK): 3.8 million ADRs

Sources:13D/A by Qi Ji (Oct 20, 2025) ↗13D/A by Tong Tong Zhao (Oct 20, 2025) ↗13G by JPMorgan Chase (Oct 13, 2026) ↗All of the company's proxy statements on EDGAR ↗

We hold 13D and 13G filings made since Dec 23, 2024: a holder above 5% that has not filed since then does not appear here.

H World Group revenue

H World Group reported annual revenue of $3.62 billion for fiscal year 2025 (year ended December 31, 2025), according to its Form 20-F filed with the SEC (XBRL data).

Concentrated managers
10
All 13F: 254
Consensus
13/100
across 10 concentrated managersRanks by accumulation, portfolio weight and number of managers; it does not say more are buying than selling.
Price at Jun 30, 2026 (per 13F)
$41.72
-17.0% in the quarter · reported value ÷ shares, not the quote · See current quote ↗

Quarter flow (concentrated managers)

Change in managers (9 → 10): 0 opened · 0 exited · 1 more with no comparable data = +1

“No comparable data”: managers whose previous-quarter portfolio we cannot compare (first 13F, or they did not file that quarter), plus spin-offs and corporate exits (mergers, delistings). They change the count without being a clean buy or sale. It is a net figure: “more” when more of them enter the count than leave it, “fewer” when it is the other way round. Here: 1 entered with no comparable quarter.

Net flow in the quarter: −$58.0M (−1.4 M shares) · bought $19.6M and sold $77.6MShares concentrated managers added minus those they cut, valued at the 13F quarter-end implied price, not each trade's price. It is a different measure from the change in managers: the two can have opposite signs.

Concentrated managers holding it

Up to 15, sorted by position value. The percentage is the weight in each manager's portfolio.

Largest holders of HTHT (all 13F filers)

The 10 13F filers with the most shares as of Jun 30, 2026, whatever their type (index firms usually come first). “Change”: shares added or cut versus the previous quarter, split-adjusted; “no data” = there is no comparable portfolio for the previous quarter (no filing, or a filing with its holdings under confidential treatment). “% of the company” only where shares outstanding are up to date. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. With a free account: the top 25, the largest buyers and the largest sellers.

Fundamentals

12-month figures to Dec 31, 2025 · balance sheet as of Dec 31, 2025.

Profitability
Operating margin
26.9%
Net margin
20.1%
ROE
39.7%
Growth
Revenue (TTM)
$3.6 bn
Revenue growth
10.5%
Net income (TTM)
$726M
Balance sheet
Net debt / EBITDA
−0.8x
Free cash flow (TTM)
—
Quality vs sector
84/100

Figures from the statements the company filed with the SEC (10-K, 10-Q). Free cash flow = operating cash flow − capital expenditures; empty if the company does not report capex. “Quality vs sector”: 0 to 100, the average of its percentiles in ROE, operating margin, free-cash-flow margin, revenue and earnings growth and net debt / EBITDA (at least 3 needed) against companies in its sector above $300M. How each figure is calculated

Shares outstanding: buybacks and dilution

Diluted shares by fiscal year (split-adjusted)

2025: 3.25 bn

3.35 bn0
20162025

There is a jump that may be an undetected split: we do not show the changes.

Buybacks (FY 2025)
$112M
Share issuance
no data
Stock-based compensation
$60.0M1.7% of revenue
Dividends paid
$559M

From the statements the company filed with the SEC (10-K). The change compares average diluted shares of each fiscal year, on today's basis: negative = it bought back more than it issued; positive = dilution. “No data” = the company does not report that item under a tag we can read; it does not mean zero.

Earnings quality and debt

Operating cash flow ÷ net income (12 months)
1.65
Interest coverage (operating income ÷ interest)
20.3 timesfiscal 2025
Debt due within 12 months
$771M0.35 times cash and investments

From the figures the company filed with the SEC. Cash flow over net income near or above 1 means earnings are collected in cash; far below, that part is accounting. Coverage says how many times operating income pays the latest fiscal year's interest. Maturities come from the debt note of the latest annual report, counted from its closing date. “No data” never means zero.

Insiders (Form 4)

Officers and directors who bought (6 m)
0
Amount (6 m)
$0
CEO/CFO bought (12 m)
No

10% owners who bought (6 m): 0

Open-market purchases, excluding 10b5-1 plans. Officers and directors only; joint filers of the same purchase count as one. 10% owners with no role are shown separately. 0 = nobody bought; “no data” = we do not have its Form 4 filings.

Each of the company's Form 4 filings, on EDGAR ↗Latest trades, with date and filing →

Above 5% (13D/13G)

Disclosed stakes, with their amendments. A filing is not always a purchase: there are also reductions and changes of filing entity.

This list may be incomplete: we hold 13D and 13G filings made since Dec 23, 2024. A holder above 5% that has not filed anything since then is not shown here.

Above 5% over time (13D/13G)

Each holder with its filings in order. History since December 2024.

This company filed no 8-K forms in the last year. Foreign companies listed in the US (ADRs) report material events on forms 6-K and 20-F, and ETFs and funds do not file 8-Ks. If it is a foreign company listed in the US through ADRs (American Depositary Receipts), what trades are bank-issued certificates that represent shares from its home market. See its filings on EDGAR ↗

Other Consumer Discretionary stocks in managers' portfolios

Same sector and a similar number of concentrated managers holding them. It is a list to keep exploring, not a recommendation.

All of Consumer Discretionary →

Follow HTHT for free

If someone reports a 5%+ stake, we email you (if you turn it on). And when you come back, see whether concentrated managers got in or out. No credit card.

Follow HTHT